Terms: = Breast cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED AND Prognosis
37 results:
1. MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner.
Castell A; Yan Q; Fawkner K; Bazzar W; Zhang F; Wickström M; Alzrigat M; Franco M; Krona C; Cameron DP; Dyberg C; Olsen TK; Verschut V; Schmidt L; Lim SY; Mahmoud L; Hydbring P; Lehmann S; Baranello L; Nelander S; Johnsen JI; Larsson LG
Cancer Res Commun; 2022 Mar; 2(3):182-201. PubMed ID: 36874405
[TBL] [Abstract] [Full Text] [Related]
2. TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative breast cancer Progression.
López-Tejada A; Griñán-Lisón C; González-González A; Cara FE; Luque RJ; Rosa-Garrido C; Blaya-Cánovas JL; Navarro-Ocón A; Valenzuela-Torres M; Parra-López M; Calahorra J; Blancas I; Marchal JA; Granados-Principal S
Int J Biol Sci; 2023; 19(1):204-224. PubMed ID: 36594086
[TBL] [Abstract] [Full Text] [Related]
3. SMAD9-mycn positive feedback loop represents a unique dependency for mycn-amplified neuroblastoma.
Tan K; Mo J; Li M; Dong Y; Han Y; Sun X; Ma Y; Zhu K; Wu W; Lu L; Liu J; Zhao K; Zhang L; Tang Y; Lv Z
J Exp Clin Cancer Res; 2022 Dec; 41(1):352. PubMed ID: 36539767
[TBL] [Abstract] [Full Text] [Related]
4. MiR-181a-5p facilitates proliferation, invasion, and glycolysis of breast cancer through NDRG2-mediated activation of PTEN/AKT pathway.
Zhai Z; Mu T; Zhao L; Li Y; Zhu D; Pan Y
Bioengineered; 2022 Jan; 13(1):83-95. PubMed ID: 34951340
[TBL] [Abstract] [Full Text] [Related]
5. The presence of Y674/Y675 phosphorylated NTRK1 via TP53 repression of PTPN6 expression as a potential prognostic marker in neuroblastoma.
Youssef G; Gillett C; Rampling D; Chagtai T; Virasami A; Barton J; Edwards D; Sebire N; Anderson J; Montano X
Hum Pathol; 2019 Apr; 86():182-192. PubMed ID: 30594749
[TBL] [Abstract] [Full Text] [Related]
6. Up-regulation of the kinase gene
Godbole M; Togar T; Patel K; Dharavath B; Yadav N; Janjuha S; Gardi N; Tiwary K; Terwadkar P; Desai S; Prasad R; Dhamne H; Karve K; Salunkhe S; Kawle D; Chandrani P; Dutt S; Gupta S; Badwe RA; Dutt A
J Biol Chem; 2018 Dec; 293(50):19263-19276. PubMed ID: 30337371
[TBL] [Abstract] [Full Text] [Related]
7. NDRG1 regulates neutral lipid metabolism in breast cancer cells.
Sevinsky CJ; Khan F; Kokabee L; Darehshouri A; Maddipati KR; Conklin DS
Breast Cancer Res; 2018 Jun; 20(1):55. PubMed ID: 29898756
[TBL] [Abstract] [Full Text] [Related]
8. Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome.
Haldar R; Shaashua L; Lavon H; Lyons YA; Zmora O; Sharon E; Birnbaum Y; Allweis T; Sood AK; Barshack I; Cole S; Ben-Eliyahu S
Brain Behav Immun; 2018 Oct; 73():294-309. PubMed ID: 29800703
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive molecular biomarker identification in breast cancer brain metastases.
Schulten HJ; Bangash M; Karim S; Dallol A; Hussein D; Merdad A; Al-Thoubaity FK; Al-Maghrabi J; Jamal A; Al-Ghamdi F; Choudhry H; Baeesa SS; Chaudhary AG; Al-Qahtani MH
J Transl Med; 2017 Dec; 15(1):269. PubMed ID: 29287594
[TBL] [Abstract] [Full Text] [Related]
10. Predictive and prognostic potential of volume-based metabolic variables obtained by a baseline
Garcia-Vicente AM; Pérez-Beteta J; Amo-Salas M; Molina D; Jimenez-Londoño GA; Soriano-Castrejón AM; Pena Pardo FJ; Martínez-González A
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(2):73-79. PubMed ID: 29102649
[TBL] [Abstract] [Full Text] [Related]
11. Clinical evaluation of integrated panel testing by next-generation sequencing for somatic mutations in neuroblastomas with mycn unamplification.
Cao Y; Jin Y; Yu J; Wang J; Qiu Y; Duan X; Ye Y; Cheng Y; Dong L; Feng X; Wang D; Li Z; Tian X; Wang H; Yan J; Zhao Q
Oncotarget; 2017 Jul; 8(30):49689-49701. PubMed ID: 28591696
[TBL] [Abstract] [Full Text] [Related]
12. A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated cancers.
Jung M; Russell AJ; Liu B; George J; Liu PY; Liu T; DeFazio A; Bowtell DD; Oberthuer A; London WB; Fletcher JI; Haber M; Norris MD; Henderson MJ
Cancer Res; 2017 Feb; 77(4):971-981. PubMed ID: 27923830
[TBL] [Abstract] [Full Text] [Related]
13. Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 Axis.
Verma N; Müller AK; Kothari C; Panayotopoulou E; Kedan A; Selitrennik M; Mills GB; Nguyen LK; Shin S; Karn T; Holtrich U; Lev S
Cancer Res; 2017 Jan; 77(1):86-99. PubMed ID: 27793840
[TBL] [Abstract] [Full Text] [Related]
14. Aryl Hydrocarbon Receptor Activates NDRG1 Transcription under Hypoxia in breast cancer Cells.
Li EY; Huang WY; Chang YC; Tsai MH; Chuang EY; Kuok QY; Bai ST; Chao LY; Sher YP; Lai LC
Sci Rep; 2016 Feb; 6():20808. PubMed ID: 26852918
[TBL] [Abstract] [Full Text] [Related]
15. Long noncoding RNAs and neuroblastoma.
Pandey GK; Kanduri C
Oncotarget; 2015 Jul; 6(21):18265-75. PubMed ID: 26087192
[TBL] [Abstract] [Full Text] [Related]
16. n-myc downstream-regulated gene 2 expression is associated with glucose transport and correlated with prognosis in breast carcinoma.
Ma J; Liu W; Guo H; Li S; Cao W; Du X; Lei S; Hou W; Xiong L; Yao L; Li N; Li Y
Breast Cancer Res; 2014 Mar; 16(2):R27. PubMed ID: 24636131
[TBL] [Abstract] [Full Text] [Related]
17. Aberrant NDRG1 methylation associated with its decreased expression and clinicopathological significance in breast cancer.
Han LL; Hou L; Zhou MJ; Ma ZL; Lin DL; Wu L; Ge YL
J Biomed Sci; 2013 Jul; 20(1):52. PubMed ID: 23899187
[TBL] [Abstract] [Full Text] [Related]
18. Expression of NDRG2 in human lung cancer and its correlation with prognosis.
Li SJ; Wang WY; Li B; Chen B; Zhang B; Wang X; Chen CS; Zhao QC; Shi H; Yao L
Med Oncol; 2013 Mar; 30(1):421. PubMed ID: 23307246
[TBL] [Abstract] [Full Text] [Related]
19. Reduced n-myc downstream-regulated gene 2 expression is associated with CD24 upregulation and poor prognosis in patients with lung adenocarcinoma.
Wang H; Wang W; Wang X; Cai K; Wu H; Ju Q; Huang Z; Gao X
Med Oncol; 2012 Dec; 29(5):3162-8. PubMed ID: 22528516
[TBL] [Abstract] [Full Text] [Related]
20. NDRG2 down-regulation and CD24 up-regulation promote tumor aggravation and poor survival in patients with gallbladder carcinoma.
Song SP; Zhang SB; Liu R; Yao L; Hao YQ; Liao MM; Zhang YD; Li ZH
Med Oncol; 2012 Sep; 29(3):1879-85. PubMed ID: 22135002
[TBL] [Abstract] [Full Text] [Related]
[Next]
